URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Aram Hezel

Concepts (204)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Pancreatic Neoplasms
13
2006
84
4.030
Why?
Biliary Tract Neoplasms
3
2008
6
2.200
Why?
Carcinoma, Pancreatic Ductal
7
2006
13
1.950
Why?
Cholangiocarcinoma
4
2008
12
1.900
Why?
Liver Neoplasms
4
2009
155
1.830
Why?
Protein-Serine-Threonine Kinases
6
2002
287
1.540
Why?
Pancreas
3
2006
127
1.260
Why?
Disease Models, Animal
7
2006
974
1.210
Why?
Gallbladder Neoplasms
3
2010
8
1.190
Why?
Proto-Oncogene Proteins p21(ras)
3
2011
16
1.110
Why?
Phosphatidylinositol 3-Kinases
5
2007
164
1.100
Why?
Tumor Suppressor Protein p53
5
2001
140
1.060
Why?
Carcinoma, Hepatocellular
2
2009
71
0.960
Why?
Integrins
1
2012
48
0.850
Why?
Signal Transduction
9
2005
1629
0.840
Why?
Antigens, Neoplasm
1
2012
109
0.810
Why?
Molecular Targeted Therapy
1
2011
20
0.770
Why?
Radiosurgery
1
2011
73
0.770
Why?
Colorectal Neoplasms
2
2007
143
0.710
Why?
Transforming Growth Factor beta
2
2006
411
0.710
Why?
Cellular Structures
1
2008
3
0.690
Why?
Carcinoma
1
2011
194
0.680
Why?
Genomic Instability
2
2005
20
0.680
Why?
Proto-Oncogene Proteins c-pim-1
1
2008
1
0.680
Why?
Telomere
2
2005
27
0.670
Why?
Liver Transplantation
1
2011
244
0.670
Why?
Genes, ras
6
2001
34
0.660
Why?
Neoplastic Syndromes, Hereditary
1
2008
1
0.650
Why?
Cystadenoma, Serous
1
2008
2
0.650
Why?
Disease Progression
7
2006
533
0.630
Why?
Proto-Oncogene Proteins
4
2007
301
0.610
Why?
ras Proteins
3
2010
38
0.580
Why?
Adenocarcinoma
5
2006
483
0.570
Why?
Mice
17
1999
6206
0.570
Why?
Animals
22
1999
16416
0.570
Why?
Tumor Markers, Biological
1
2008
240
0.560
Why?
Genes, Tumor Suppressor
4
2002
49
0.510
Why?
Antineoplastic Agents
4
2007
628
0.480
Why?
Humans
23
2005
37165
0.480
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
436
0.480
Why?
Mutation
5
2008
1226
0.450
Why?
Protein Kinases
3
2007
124
0.440
Why?
Bile Ducts, Intrahepatic
2
2011
8
0.410
Why?
Bile Duct Neoplasms
2
2011
14
0.410
Why?
Neoplasms
1
2008
743
0.410
Why?
TOR Serine-Threonine Kinases
3
2007
28
0.400
Why?
Deoxycytidine
3
2008
28
0.400
Why?
Indoles
2
2009
104
0.360
Why?
Lung Neoplasms
3
2006
435
0.350
Why?
Aging
1
2005
705
0.330
Why?
Cell Polarity
2
2008
30
0.330
Why?
Peutz-Jeghers Syndrome
2
2002
3
0.280
Why?
Cell Transformation, Neoplastic
3
2002
138
0.280
Why?
Treatment Outcome
4
2007
2671
0.260
Why?
Mice, Mutant Strains
5
1999
129
0.260
Why?
Cyclin-Dependent Kinase Inhibitor p16
4
2001
13
0.250
Why?
Middle Aged
7
2008
10013
0.240
Why?
Gene Deletion
4
2002
204
0.240
Why?
Aged
5
2008
7392
0.220
Why?
Isocitrate Dehydrogenase
1
2011
23
0.210
Why?
Waiting Lists
1
2011
12
0.210
Why?
Tumor Burden
1
2011
22
0.210
Why?
Genetic Engineering
1
2012
21
0.210
Why?
Dose Fractionation
1
2011
57
0.210
Why?
Tumor Suppressor Protein p14ARF
3
2001
5
0.210
Why?
Necrosis
1
2011
103
0.210
Why?
beta Karyopherins
1
2011
13
0.200
Why?
PTEN Phosphohydrolase
1
2011
16
0.200
Why?
Organ Size
1
2011
194
0.200
Why?
Validation Studies as Topic
1
2011
3
0.200
Why?
Tubulin
1
2011
64
0.200
Why?
Mice, Transgenic
3
2008
770
0.190
Why?
Immunohistochemistry
2
2006
1082
0.190
Why?
Cisplatin
1
2011
93
0.190
Why?
DNA Mutational Analysis
1
2011
192
0.190
Why?
Female
8
2007
20222
0.180
Why?
Proto-Oncogene Proteins c-akt
2
2007
133
0.180
Why?
Drug Therapy, Combination
1
2011
397
0.180
Why?
NF-kappa B
2
2007
434
0.180
Why?
Male
7
2008
20139
0.170
Why?
Pyrroles
1
2009
21
0.170
Why?
MAP Kinase Signaling System
1
2010
97
0.170
Why?
Amyloid Precursor Protein Secretases
1
2009
14
0.170
Why?
Pancreatic Ducts
1
2008
3
0.170
Why?
p21-Activated Kinases
1
2008
3
0.170
Why?
Aged, 80 and over
3
2009
2588
0.170
Why?
Mice, Knockout
3
2002
922
0.170
Why?
rho GTP-Binding Proteins
1
2008
23
0.170
Why?
Sirolimus
1
2008
30
0.170
Why?
Liver
2
1999
884
0.160
Why?
Metaplasia
1
2008
33
0.160
Why?
Tight Junctions
1
2008
16
0.160
Why?
Neoplasms, Squamous Cell
1
2008
10
0.160
Why?
Receptors, Notch
1
2009
66
0.160
Why?
Fluorouracil
1
2008
78
0.160
Why?
Islets of Langerhans
1
2008
87
0.160
Why?
Carcinogens
1
2008
64
0.160
Why?
Cytoskeleton
1
2008
85
0.150
Why?
Proto-Oncogene Proteins c-met
1
2007
17
0.150
Why?
Receptors, Growth Factor
1
2007
29
0.150
Why?
Energy Metabolism
1
2008
137
0.150
Why?
Magnesium Compounds
1
2007
5
0.150
Why?
Cytokines
1
2011
575
0.150
Why?
Cohort Studies
1
2011
984
0.150
Why?
Prednisolone
1
2007
25
0.150
Why?
Antibodies, Monoclonal
1
2011
748
0.150
Why?
Smad4 Protein
1
2006
16
0.150
Why?
src-Family Kinases
1
2007
70
0.150
Why?
Calcium Oxalate
1
2007
32
0.150
Why?
Protein Processing, Post-Translational
1
2008
141
0.140
Why?
Cats
1
2007
216
0.140
Why?
Protein Kinase Inhibitors
1
2007
97
0.140
Why?
Receptor, Epidermal Growth Factor
1
2007
96
0.140
Why?
Models, Biological
2
2007
1029
0.140
Why?
Phosphates
1
2007
152
0.140
Why?
Biological Markers
1
2009
564
0.140
Why?
Retinoblastoma Protein
2
2001
34
0.140
Why?
Genes, p53
1
2006
51
0.140
Why?
Adult
5
2008
11572
0.140
Why?
Anti-Inflammatory Agents
1
2007
115
0.130
Why?
Enzyme Activation
1
2008
611
0.130
Why?
Cell Line, Tumor
4
2006
576
0.130
Why?
Randomized Controlled Trials as Topic
1
2008
415
0.130
Why?
Epithelial Cells
1
2008
332
0.130
Why?
Prognosis
1
2008
1078
0.130
Why?
Retrospective Studies
1
2011
2302
0.130
Why?
Skin Neoplasms
1
2008
230
0.130
Why?
Cell Proliferation
1
2008
520
0.130
Why?
Phosphorylation
1
2008
839
0.130
Why?
Administration, Oral
3
2007
314
0.120
Why?
Pneumonia
1
2006
192
0.120
Why?
Intestinal Polyps
1
2002
15
0.110
Why?
Drug Resistance, Neoplasm
2
2008
56
0.090
Why?
Melanoma
1
2001
132
0.090
Why?
Neoplasm Metastasis
2
2008
229
0.080
Why?
Carrier Proteins
1
2002
446
0.080
Why?
Mutagenesis
1
1999
142
0.080
Why?
DNA Repair
1
1999
173
0.080
Why?
Phenotype
2
2006
756
0.060
Why?
DNA-Binding Proteins
1
1999
691
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2001
266
0.060
Why?
Demography
1
2011
103
0.050
Why?
Animals, Genetically Modified
1
2011
51
0.050
Why?
Genotype
1
2011
473
0.050
Why?
Cyclic S-Oxides
1
2009
1
0.040
Why?
Chemokine CXCL12
1
2009
35
0.040
Why?
Thiadiazoles
1
2009
12
0.040
Why?
Oncogene Protein v-akt
1
2008
5
0.040
Why?
Survival Analysis
1
2011
589
0.040
Why?
Cell Line, Transformed
1
2008
63
0.040
Why?
Neoplasm Staging
1
2010
354
0.040
Why?
Genomics
1
2008
49
0.040
Why?
Mice, Nude
1
2008
179
0.040
Why?
Combined Modality Therapy
1
2010
491
0.040
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
36
0.040
Why?
Neoplasm Invasiveness
1
2008
160
0.040
Why?
Survival Rate
1
2010
619
0.040
Why?
Transcription, Genetic
1
2012
824
0.040
Why?
Epidermis
1
2008
83
0.040
Why?
Cat Diseases
1
2007
2
0.040
Why?
Urinalysis
1
2007
18
0.040
Why?
Stromal Cells
1
2007
71
0.040
Why?
Urinary Calculi
1
2007
32
0.040
Why?
Young Adult
1
2011
1084
0.040
Why?
Cross-Over Studies
1
2007
119
0.040
Why?
Interleukin-6
1
2009
339
0.040
Why?
Alleles
1
2006
206
0.040
Why?
Homozygote
1
2006
95
0.030
Why?
Cell Movement
1
2008
378
0.030
Why?
Cyclooxygenase 2
1
2007
230
0.030
Why?
Macrophages, Alveolar
1
2006
117
0.030
Why?
Mice, Inbred C57BL
1
2011
1700
0.030
Why?
Stem Cells
1
2009
361
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2006
301
0.030
Why?
DNA Primers
1
2006
422
0.030
Why?
Cell Line
1
2009
1623
0.030
Why?
Time Factors
1
2011
3234
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
543
0.030
Why?
Magnetic Resonance Imaging
1
2009
1019
0.030
Why?
Culture Media, Conditioned
1
2002
66
0.030
Why?
Child
1
2011
4342
0.030
Why?
Gene Targeting
1
2002
70
0.030
Why?
Cell Aging
1
2002
55
0.030
Why?
Adolescent
1
2011
5044
0.030
Why?
Base Sequence
1
2006
1721
0.030
Why?
cdc25 Phosphatases
1
2001
1
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2001
46
0.020
Why?
Cyclin D1
1
2001
32
0.020
Why?
S Phase
1
2001
46
0.020
Why?
Gene Silencing
1
2001
41
0.020
Why?
G1 Phase
1
2001
53
0.020
Why?
Cyclins
1
2001
51
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2001
71
0.020
Why?
Cell Differentiation
1
2006
1127
0.020
Why?
In Situ Hybridization
1
2001
332
0.020
Why?
Xeroderma Pigmentosum Group A Protein
1
1999
2
0.020
Why?
Chimera
1
1999
35
0.020
Why?
Lac Operon
1
1999
62
0.020
Why?
Fibroblasts
1
2002
545
0.020
Why?
Genes, Reporter
1
1999
209
0.020
Why?
Proteins
1
2001
470
0.020
Why?
Age Factors
1
1999
1152
0.020
Why?
RNA, Messenger
1
2002
1893
0.020
Why?
Brain
1
1999
1228
0.010
Why?

Visualizations


Hezel's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department